Omicron News and Research

RSS

COVID-19 linked to long-lasting cognitive deficits, study finds

Study in England suggests that COVID-19 may lead to long-term cognitive deficits, with more severe impacts observed in individuals infected early in the pandemic or with prolonged symptoms.

4 Mar 2024

Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2

The ongoing COVID-19 pandemic caused by SARS-CoV-2 has caused serious damage to public health and the global economy, and one strategy to combat COVID-19 has been the development of broadly neutralizing antibodies for prophylactic and therapeutic use.

1 Mar 2024

Study shows the benefits of locally administered intranasal live-attenuated SARS-CoV-2 vaccine

Rocketvax AG, together with the German Research Foundation (DFG), has financially supported a study carried out as part of a joint project of the Swiss National Science Foundation (SNSF, National Research Program "Covid-19," NRP 78) and the German Research Foundation (DFG) "Recoding the SARS-CoV-2 Genome - A Multidisciplinary Approach to Generate Live-Attenuated Coronavirus Vaccines."

27 Feb 2024

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

A study published in Immunity shows that antibody responses to SARS-CoV-2 infection and vaccination are long-lasting, with an initial decline followed by stabilization after seven to nine months, highlighting the effectiveness of mRNA vaccines and the importance of hybrid immunity.

25 Feb 2024

Neonates of booster-vaccinated mothers have lower COVID-19 risk and better outcomes

An international study of COVID-19 in pregnancy, which included Ann & Robert H. Lurie Children's Hospital of Chicago, found that neonates of booster-vaccinated mothers had less risk of being infected with COVID-19 compared to those of unvaccinated mothers.

23 Feb 2024

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin.

23 Feb 2024

Study reveals high prevalence of persistent COVID-19 infections in general population

A new study led by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more.

21 Feb 2024

Understanding the varied impact of COVID-19 in Shanghai and Hong Kong: A comparative analysis

Announcing a new article publication for Zoonoses journal. Shanghai and Hong Kong, China, experienced an outbreak of COVID-19 in early 2022.

15 Feb 2024

Study shows ritonavir-boosted nirmatrelvir remains effective against new omicron variants in the U.S

The effectiveness of ritonavir-boosted nirmatrelvir (NMV-r) against Omicron variants.

13 Feb 2024

COVID-19's lasting impact on smell and brain health unveiled

Study reviews the impact of COVID-19 on olfactory dysfunction and its link to neurocognitive disorders, highlighting MRI findings and potential treatments for smell loss.

12 Feb 2024

Long COVID in children: A closer look reveals lasting impacts

A comprehensive review in Pediatrics highlights the significant impact of post-acute sequelae of SARS-CoV-2 (PASC) in children, revealing a wide range of long-term symptoms and the need for further research on its prevalence, risk factors, and mechanisms.

11 Feb 2024

Understanding the virological properties of SARS-CoV-2 variant JN.1

Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a worldwide threat.

9 Feb 2024

MHRA authorizes COVID-19 vaccines: Comirnaty and Nuvaxovid gain approvals

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a change to the license of the Comirnaty Omicron XBB.1.5 30 micrograms/dose (single-dose vials) after it was found to meet the UK regulator's standards of safety, quality and effectiveness.

9 Feb 2024

Omicron News and Research

COVID-19 linked to long-lasting cognitive deficits, study finds

Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2

Study shows the benefits of locally administered intranasal live-attenuated SARS-CoV-2 vaccine

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

Neonates of booster-vaccinated mothers have lower COVID-19 risk and better outcomes

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Study reveals high prevalence of persistent COVID-19 infections in general population

Understanding the varied impact of COVID-19 in Shanghai and Hong Kong: A comparative analysis

Study shows ritonavir-boosted nirmatrelvir remains effective against new omicron variants in the U.S

COVID-19's lasting impact on smell and brain health unveiled

Long COVID in children: A closer look reveals lasting impacts

Understanding the virological properties of SARS-CoV-2 variant JN.1

MHRA authorizes COVID-19 vaccines: Comirnaty and Nuvaxovid gain approvals

XBB.1.5 updated COVID vaccine booster offers 54% increased protection against symptomatic infection

Evaluating effectiveness of various COVID-19 vaccine doses after primary vaccination

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

Neonates exposed to SARS-CoV-2 in utero at higher risk of respiratory distress, study finds

Study offers insights into who's at risk for long COVID among immunocompromised patients

UK Biobank research reveals significant impact of type 2 diabetes on COVID-19 outcomes

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News